Reading time: < 1 minute
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
Early-phase Trial Demonstrates Shrinkage in Pediatric Neural Tumors
HHS, NIH Take Steps to Enhance Transparency, Public Access to Clinical Trial Results
Ebola Outbreak Increases Pressure to Start Vaccine Trials
About the Author
